Literature DB >> 25100889

Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae: a case-case-control study.

Viviana Gómez Rueda1, John Jairo Zuleta Tobón1.   

Abstract

OBJETIVE: To evaluate the association between quinolone exposure and the emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) and to estimate CRKP-specific mortality.
METHODS: Case-case-control study implemented in a tertiary care institution. Three groups of patients were analyzed: 61 consecutive cases of infection with CRKP (Group I); 61 randomly chosen cases of patients infected with carbapenem-sensitive Klebsiella pneumoniae (CSKP; Group II); and 122 randomly chosen controls without CRKP or CSKP infection. Matching was based on the length of stay in intensive care unit and the date of bacterial isolation. An active search was performed for patients with CRKP and CSKP infection, and prospective cases were included in the study. We compared the results for Groups I and II against those for the controls by using two conditional logistic regression analyses that included infection as the dependent variable and controlled for time at risk and comorbidities.
RESULTS: Exposure to quinolones was not associated with CRKP infection: no association was found in the analysis of CRKP with the controls (OR=1.7; 95% CI: 0.2-6.5) or in the analysis of CSKP against the controls (OR=0.6; 95% CI: 0.2-1.6). Use of carbapenems (OR=3.3; 95% CI: 1.2-9.3) and colonization with CRKP (OR=3.3; 95% IC: 1.2-9.3) were specific risk factors for infection with CRKP. Mortality associated with CRKP was 61.3%.
CONCLUSION: No association was found between exposure to quinolones and infection with CRKP; however, colonization by CRKP and use of carbapenems are risk factors for infection with CRKP.

Entities:  

Keywords:  Klebsiella pneumoniae; carbapenems; case-control studies; quinolones; risk factors

Mesh:

Substances:

Year:  2014        PMID: 25100889      PMCID: PMC4123582     

Source DB:  PubMed          Journal:  Colomb Med (Cali)        ISSN: 0120-8322


  25 in total

1.  Looking for risk factors for the acquisition of antibiotic resistance: a 21st-century approach.

Authors:  David L Paterson
Journal:  Clin Infect Dis       Date:  2002-05-23       Impact factor: 9.079

2.  Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant.

Authors:  Christopher J Gregory; Eloisa Llata; Nicholas Stine; Carolyn Gould; Luis Manuel Santiago; Guillermo J Vazquez; Iraida E Robledo; Arjun Srinivasan; Richard V Goering; Kay M Tomashek
Journal:  Infect Control Hosp Epidemiol       Date:  2010-05       Impact factor: 3.254

Review 3.  Methodologic issues of case-control studies: a review of established and newly recognized limitations.

Authors:  Erika M C D'Agata
Journal:  Infect Control Hosp Epidemiol       Date:  2005-04       Impact factor: 3.254

4.  Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.

Authors:  Eleni Mouloudi; Euthymia Protonotariou; Alexia Zagorianou; Elias Iosifidis; Areti Karapanagiotou; Tatiana Giasnetsova; Agoritsa Tsioka; Emmanuel Roilides; Danai Sofianou; Nikoleta Gritsi-Gerogianni
Journal:  Infect Control Hosp Epidemiol       Date:  2010-10-25       Impact factor: 3.254

Review 5.  Antibiotic-selective environments.

Authors:  F Baquero; M C Negri; M I Morosini; J Blázquez
Journal:  Clin Infect Dis       Date:  1998-08       Impact factor: 9.079

6.  Antibiotic use and the risk of carbapenem-resistant extended-spectrum-{beta}-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study.

Authors:  Evangelos I Kritsotakis; Constantinos Tsioutis; Maria Roumbelaki; Athanasia Christidou; Achilleas Gikas
Journal:  J Antimicrob Chemother       Date:  2011-03-31       Impact factor: 5.790

7.  Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.

Authors:  Dandan Wu; Jiachang Cai; Jin Liu
Journal:  South Med J       Date:  2011-02       Impact factor: 0.954

8.  Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns.

Authors:  Khetam Hussein; Hanna Sprecher; Tania Mashiach; Ilana Oren; Imad Kassis; Renato Finkelstein
Journal:  Infect Control Hosp Epidemiol       Date:  2009-07       Impact factor: 3.254

Review 9.  The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.

Authors:  Patrice Nordmann; Gaelle Cuzon; Thierry Naas
Journal:  Lancet Infect Dis       Date:  2009-04       Impact factor: 25.071

10.  Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.

Authors:  Mitchell J Schwaber; Shiri Klarfeld-Lidji; Shiri Navon-Venezia; David Schwartz; Azita Leavitt; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

View more
  23 in total

1.  Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study.

Authors:  Yang Jiao; Yanghua Qin; Jiajun Liu; Qiang Li; Yuchao Dong; Yan Shang; Yi Huang; Rui Liu
Journal:  Pathog Glob Health       Date:  2015-02-24       Impact factor: 2.894

2.  [Risk factors for nosocomial infection of carbapenem-resistant Klebsiella pneumoniae in children: a single-center matched case-case-control study].

Authors:  Lu Dai; Feng Li; Hong-Chao Jiang; Li Jiang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022 Sept 15

3.  A Two-Year Surveillance in Five Colombian Tertiary Care Hospitals Reveals High Frequency of Non-CG258 Clones of Carbapenem-Resistant Klebsiella pneumoniae with Distinct Clinical Characteristics.

Authors:  Ana M Ocampo; Liang Chen; Astrid V Cienfuegos; Gustavo Roncancio; Kalyan D Chavda; Barry N Kreiswirth; J Natalia Jiménez
Journal:  Antimicrob Agents Chemother       Date:  2015-10-26       Impact factor: 5.191

4.  Nosocomial outbreak of KPC-2- and NDM-1-producing Klebsiella pneumoniae in a neonatal ward: a retrospective study.

Authors:  Jing Yu; Kun Tan; Zhihui Rong; Yue Wang; Zhongju Chen; Xuhui Zhu; Li Wu; Li Tan; Wei Xiong; Ziyong Sun; Ling Chen
Journal:  BMC Infect Dis       Date:  2016-10-12       Impact factor: 3.090

Review 5.  Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis.

Authors:  Raspail Carrel Founou; Luria Leslie Founou; Sabiha Yusuf Essack
Journal:  PLoS One       Date:  2017-12-21       Impact factor: 3.240

6.  Carbapenem-resistant Klebsiella pneumoniae in Barbados: Driving change in practice at the national level.

Authors:  Corey Forde; Bryan Stierman; Pilar Ramon-Pardo; Thais Dos Santos; Nalini Singh
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

Review 7.  Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae.

Authors:  Liangfei Xu; Xiaoxi Sun; Xiaoling Ma
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-03-29       Impact factor: 3.944

8.  Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients.

Authors:  Ye Zhang; Ling-Yun Guo; Wen-Qi Song; Yan Wang; Fang Dong; Gang Liu
Journal:  BMC Infect Dis       Date:  2018-05-31       Impact factor: 3.090

9.  Carbapenem-resistant Enterobacteriaceae: Prevalence and Risk Factors in a Single Community-Based Hospital in Korea.

Authors:  Hyo Jin Lee; Jae Ki Choi; Sung Yeon Cho; Si Hyun Kim; Sun Hee Park; Su Mi Choi; Dong Gun Lee; Jung Hyun Choi; Jin Hong Yoo
Journal:  Infect Chemother       Date:  2016-09-08

10.  Invasive Klebsiella pneumoniae Infections in Community-Settings and Healthcare Settings.

Authors:  Yue Qiu; Daojiong Lin; Yi Xu; Yibing Cheng; Fang Wang; Qingxiong Zhu; Chunhui Zhu; Chaomin Wan; Yu Zhu; Jianning Tong; Rui Li; Qionghua Zhou; Minxia Chen; Qingwen Shan; Zhiqiang Zhuo; Caihong Wang; Shiyong Zhao; Wen Song; Mei Zeng
Journal:  Infect Drug Resist       Date:  2021-07-12       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.